• COVID-19 - Neuropilin-1, the New Doorway for Viral Entry

  • Oct 25 2021
  • Length: 24 mins
  • Podcast

COVID-19 - Neuropilin-1, the New Doorway for Viral Entry

  • Summary

  • The additional receptor implicated in Sars-COV-2's entry process, while not exactly new, is definitely not getting the fair share of the spotlight with ACE2. Involved in many complicated pathways in normal physiology, new research points to interesting possibilities for the future of pain treatment. 

    This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics!

    Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com.

    PLEASE READ: Shane, Mickey, Cal and Justin are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health.

    A special thanks to Kelly Kerr for creating the music used in the intro and outro.
    Additional Music from Pixabay and Fesliyan Studios

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about COVID-19 - Neuropilin-1, the New Doorway for Viral Entry

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.